EIF4E and neoplasm: In all subtypes of BRCA, the expression of eIF4E was significantly higher than that in normal subjects, the expression in the luminal type was significantly higher than that in TNBC (P < 0.01), and the expression levels in tumor stages 1, 2 and 3 were significantly higher than those in the normal group.